These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 33711174)

  • 1. The Spinal Muscular Atrophy Health Index: A novel outcome for measuring how a patient feels and functions.
    Zizzi CE; Luebbe E; Mongiovi P; Hunter M; Dilek N; Garland C; Ciafaloni E; Zaidman CM; Kissel JT; McDermott MP; Johnson N; Sansone V; Heatwole CR
    Muscle Nerve; 2021 Jun; 63(6):837-844. PubMed ID: 33711174
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Facioscapulohumeral Muscular Dystrophy-Health Index: Development and evaluation of a disease-specific outcome measure.
    Varma A; Weinstein J; Seabury J; Rosero S; Engebrecht C; Wagner E; Zizzi C; Luebbe EA; Dilek N; McDermott MP; Kissel J; Sansone V; Heatwole C
    Muscle Nerve; 2023 Oct; 68(4):422-431. PubMed ID: 37610084
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessing perspectives of disease burden and clinically meaningful changes using the Spinal Muscular Atrophy Health Index in adolescents and young adults.
    Mazzella A; Cruz R; Belter L; Curry M; Dilek N; Zizzi C; Heatwole C; Jarecki J
    Muscle Nerve; 2022 Sep; 66(3):276-281. PubMed ID: 35616549
    [TBL] [Abstract][Full Text] [Related]  

  • 4. P047 The Crohn's Disease-Health Index (CD-HI): Development and Validation of a Novel, Disease-Specific Patient Reported Outcome Measure for Clinical Trials.
    Seabury J; Weinstein J; Rosero S; Varma A; Wagner E; Zizzi C; Dilek N; McDermott M; Kaat A; Saubermann L; Temple L; Rogoff S; Heatwole C
    Am J Gastroenterol; 2021 Dec; 116(Suppl 1):S12. PubMed ID: 37461965
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The amyotrophic lateral sclerosis-health index (ALS-HI): development and evaluation of a novel outcome measure.
    Varma A; Weinstein J; Seabury J; Rosero S; Zizzi C; Alexandrou D; Wagner E; Dilek N; Heatwole J; Wuu J; Caress J; Bedlack R; Granit V; Statland J; Mehta P; Benatar M; Kaat A; Heatwole C
    Amyotroph Lateral Scler Frontotemporal Degener; 2023 Aug; 24(5-6):514-522. PubMed ID: 37190795
    [No Abstract]   [Full Text] [Related]  

  • 6. The Spinal Muscular Atrophy Health Index: Italian validation of a disease-specific outcome measure.
    Sansone VA; Pirola A; Lizio A; Greco LC; Coratti G; Casiraghi J; Pane M; Pera MC; Italiano C; Messina S; Pozzi S; Sframeli M; D'Amico A; Bertini E; Bruno C; Mauro L; Salmin F; Stancanelli C; Pedemonte M; Albamonte E; Zizzi C; Heatwole C; Mercuri E;
    Neuromuscul Disord; 2021 May; 31(5):409-418. PubMed ID: 33773884
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Crohn's Disease-Health Index: Development and Evaluation of a Novel Outcome Measure.
    Varma A; Weinstein J; Seabury J; Rosero S; Wagner E; Zizzi C; Kaat A; Luebbe E; Dilek N; Heatwole J; Saubermann L; Temple L; Rogoff S; Heatwole C
    J Clin Gastroenterol; 2024 Jan; ():. PubMed ID: 38277500
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The facioscapulohumeral muscular dystrophy - health index: Italian validation of a disease-specific measure of symptomatic burden.
    Carraro E; Greco LC; Lizio A; Beretta M; Pozzi S; Casiraghi J; Becchiati S; Beshiri F; Frisoni MC; Iossa F; Heatwole C; Sansone V
    Disabil Rehabil; 2024 May; 46(10):2130-2137. PubMed ID: 37194629
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Huntington's Disease Health Index: Initial Evaluation of a Disease-Specific Patient Reported Outcome Measure.
    Brumfield OS; Zizzi CE; Dilek N; Alexandrou DG; Glidden AM; Rosero S; Weinstein J; Seabury J; Kaat A; McDermott MP; Dorsey ER; Heatwole CR
    J Huntingtons Dis; 2022; 11(2):217-226. PubMed ID: 35527560
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcome measures in a cohort of ambulatory adults with spinal muscular atrophy.
    Elsheikh B; King W; Peng J; Swoboda KJ; Reyna SP; LaSalle B; Prior TW; Arnold WD; Kissel JT; Kolb SJ
    Muscle Nerve; 2020 Feb; 61(2):187-191. PubMed ID: 31725909
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fatigability in spinal muscular atrophy: validity and reliability of endurance shuttle tests.
    Bartels B; de Groot JF; Habets LE; Wijngaarde CA; Vink W; Stam M; Asselman FL; van Eijk RPA; van der Pol WL
    Orphanet J Rare Dis; 2020 Mar; 15(1):75. PubMed ID: 32293503
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patient Reported Impact of Symptoms in Spinal Muscular Atrophy (PRISM-SMA).
    Mongiovi P; Dilek N; Garland C; Hunter M; Kissel JT; Luebbe E; McDermott MP; Johnson N; Heatwole C
    Neurology; 2018 Sep; 91(13):e1206-e1214. PubMed ID: 30143566
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Performance of the timed "up & go" test in spinal muscular atrophy.
    Dunaway S; Montes J; Garber CE; Carr B; Kramer SS; Kamil-Rosenberg S; Strauss N; Sproule D; De Vivo DC
    Muscle Nerve; 2014 Aug; 50(2):273-7. PubMed ID: 24375426
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Limb Girdle Muscular Dystrophy Health Index (LGMD-HI).
    Stouffer JA; Bates K; Thacker LR; Heatwole C; Johnson NE
    Neuromuscul Disord; 2024 Jun; 39():48-53. PubMed ID: 38795602
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Validity and reliability of the Assessment of Spondyloarthritis International Society Health Index in English-speaking patients with axial spondyloarthritis in Singapore.
    Kwan YH; Aw FF; Fong W; Phang JK; Kiltz U; Lim KK; Chew EH; Lui NL; Tan CS; Thumboo J; Østbye T; Leung YY
    Int J Rheum Dis; 2019 Sep; 22(9):1644-1651. PubMed ID: 31245926
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Six-minute walk test is reliable and valid in spinal muscular atrophy.
    Dunaway Young S; Montes J; Kramer SS; Marra J; Salazar R; Cruz R; Chiriboga CA; Garber CE; De Vivo DC
    Muscle Nerve; 2016 Nov; 54(5):836-842. PubMed ID: 27015431
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Friedreich's Ataxia-Health Index: Development and Validation of a Novel Disease-Specific Patient-Reported Outcome Measure.
    Seabury J; Rosero S; Varma A; Weinstein J; Engebrecht C; Dilek N; Heatwole J; Alexandrou D; Cohen B; Larkindale J; Lynch DR; Park C; Subramony SH; Wagner E; Walther S; Wells M; Zizzi C; Heatwole C
    Neurol Clin Pract; 2023 Oct; 13(5):e200180. PubMed ID: 37646046
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Upper limb functional assessment scale for children with Duchenne muscular dystrophy and Spinal muscular atrophy].
    Escobar RG; Lucero N; Solares C; Espinoza V; Moscoso O; Olguín P; Muñoz KT; Rosas R
    Rev Chil Pediatr; 2017 Feb; 88(1):92-99. PubMed ID: 28288228
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Responsiveness of the motor function measure in patients with spinal muscular atrophy.
    Vuillerot C; Payan C; Iwaz J; Ecochard R; Bérard C;
    Arch Phys Med Rehabil; 2013 Aug; 94(8):1555-61. PubMed ID: 23380348
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Revised Hammersmith Scale for spinal muscular atrophy: A SMA specific clinical outcome assessment tool.
    Ramsey D; Scoto M; Mayhew A; Main M; Mazzone ES; Montes J; de Sanctis R; Dunaway Young S; Salazar R; Glanzman AM; Pasternak A; Quigley J; Mirek E; Duong T; Gee R; Civitello M; Tennekoon G; Pane M; Pera MC; Bushby K; Day J; Darras BT; De Vivo D; Finkel R; Mercuri E; Muntoni F
    PLoS One; 2017; 12(2):e0172346. PubMed ID: 28222119
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.